vTv Therapeutics Inc. (VTVT)
NASDAQ·Healthcare·Biotechnology
$31.30
+0.71%
Mkt Cap $95.58M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$51.33
Range $47.00 – $58.00
Implied Upside
+64.0%
Consensus $51.33 vs current $31.30
NASDAQ·Healthcare·Biotechnology
$31.30
+0.71%
Mkt Cap $95.58M
No recent rating data.
Price Target (3 analysts)
$51.33
Range $47.00 – $58.00
+64.0%
Consensus $51.33 vs current $31.30